Research programme: integrin antagonists - SIDR

Drug Profile

Research programme: integrin antagonists - SIDR

Alternative Names: Integrin antagonists research programme - SIDR; Integrin antagonists research programme - Strathclyde Institute for Drug Research; Research programme: integrin antagonists - Strathclyde Institute for Drug Research

Latest Information Update: 27 Apr 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Strathclyde Institute for Drug Research
  • Class
  • Mechanism of Action Integrin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Inflammation

Most Recent Events

  • 27 Apr 2001 Discontinued-Preclinical for Inflammation in United Kingdom (Unknown route)
  • 29 Oct 1999 SIDR's integrin antagonists research programme is available for licensing (http://www.sidr.org)
  • 20 Jul 1999 New profile
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top